EUVIMEDEUVIMED entdecken
Open Access

Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure

Shengliang Zhang, Wafik S El-Deiry

Oncotarget · 03.05.2024 · 15 (1) · 275-284

DOI: 10.18632/oncotarget.28582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, online erschienen am 03.05.2024. Verfasst von Shengliang Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Tumor Suppressor Protein p53, Cyclin-Dependent Kinase Inhibitor p21, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p21Spike Glycoprotein, CoronavirusCell SurvivalReceptors, TNF-Related Apoptosis-Inducing LigandSARS-CoV-2HumansCell Line, TumorNeoplasmsAntineoplastic AgentsTransfectionCOVID-19

Stichwörter der Autor:innen

MDM2SARS-COV2 spikecancerchemotherapyp53

Substanzen

Proto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53MDM2 protein, humanCyclin-Dependent Kinase Inhibitor p21Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Receptors, TNF-Related Apoptosis-Inducing LigandCDKN1A protein, humanTP53 protein, humanTNFRSF10B protein, human

Autor:innen und Institutionen

  • Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
  • Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
  • Joint Program in Cancer Biology, Lifespan Health System and Brown University, Providence, RI 02912, USA.
  • Legorreta Cancer Center at Brown University, Providence, RI 02912, USA.
  • Hematology/Oncology Division, Department of Medicine, Lifespan Health System and Brown University, Providence, RI 02912, USA.

Zitieren

APA

Zhang, S., & El-Deiry, W. S. (2024). Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure. Oncotarget, 15(1), 275-284. https://doi.org/10.18632/oncotarget.28582

Vancouver

Zhang S, El-Deiry WS. Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure. Oncotarget. 2024;15(1):275-284. doi:10.18632/oncotarget.28582

BibTeX
@article{Zhang2024,
  author = {Zhang, Shengliang and El-Deiry, Wafik S},
  title = {Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure},
  journal = {Oncotarget},
  year = {2024},
  volume = {15},
  number = {1},
  pages = {275--284},
  doi = {10.18632/oncotarget.28582}
}
Kostenlos starten →